A subset of patients with familial thrombocytopenia are at increased risk of developing myeloid neoplasms during their life time, particularly those with germline autosomal dominant mutations in the RUNX1, ANKRD26, and ETV6 genes [45]. Here, ETV6 is linked to myeloid neoplasm.